Skip to main content

News

ALN
February 24, 2020
Findings from a recent meta-analysis suggested Janus kinases inhibitors were associated with an increased risk for herpes zoster infection among patients with immune-meditated inflammatory diseases.
February 24, 2020
A recent study showed rheumatologists can help patients with rheumatoid arthritis and cardiovascular risk factors, such as hypertension, lower their cardiovascular risk by implementing an easy intervention with their patient’s primary care practices.
The Dermatologist
February 24, 2020
Hidradenitis suppurativa (HS) is associated with lower quality of life. Findings from a recent study showed arthralgia can exacerbate this burden in patients.
ALN
February 19, 2020
A recent study showed mild to moderate increased risk for gastrointestinal and pulmonary adverse events, among others, as well as increased skin cancer.
ALN
February 18, 2020
A recent proof-of-concept study yielded promising results for an investigational anti-CD40 monoclonal antibody among patients with primary Sjögren syndrome.
ALN
February 14, 2020
In a recent study, researchers investigated whether dose reduction of biologics was noninferior to usual care among patients with well-controlled plaque psoriasis.
ALN
February 13, 2020
A recent study showed adding rheumatoid arthritis-specific measures to electronic health records improved physician satisfaction and the capture of disease outcomes.
The Dermatologist
February 12, 2020
The use of complementary and alternative medicine among patients with HS is very common, according to the findings of a recent survey, which also showed nearly 50% of patients did not find conventional therapy very successful for treating their skin disease.
ALN
February 11, 2020
Findings from a recent study showed patients with high rheumatoid arthritis disease activity did not receive recommended treatment changes to reduce symptoms or achieve remission.
ALN
February 10, 2020
Findings from a recent study found no evidence of severe consequences from patients who were immunosuppressed inadvertently receiving the live varicella zoster vaccine. This suggests some patients receiving immunosuppressive medications, such as biologics, may be able to receive the live vaccine to protect against varicella zoster.
Back to Top